Souders Financial Advisors Astrazeneca PLC Transaction History

Souders Financial Advisors

$639 Million
Q2 2024

A detailed history of Souders Financial Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Souders Financial Advisors holds 2,615 shares of AZN stock, worth $202,584. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,615

Previous 47,674 94.51%

Holding current value

$202,584

Previous $3.23 Million 93.71%

% of portfolio

0.03%

Previous 0.53%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 28, 2024	SELL	$66.81 - $80.83 $3.01 Million - $3.64 Million	-45,059 Reduced 94.51%	2,615 $203,000
Q1 2024 May 08, 2024	BUY	$61.03 - $69.57 $250,711 - $285,793	4,108 Added 9.43%	47,674 $3.23 Million
Q4 2023 Jan 24, 2024	BUY	$61.89 - $69.28 $49,697 - $55,631	803 Added 1.88%	43,566 $2.93 Million
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $230,606 - $254,965	3,556 Added 9.07%	42,763 $2.9 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $2.52 Million - $2.73 Million	35,983 Added 1116.1%	39,207 $2.81 Million
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $45,973 - $52,124	-728 Reduced 18.42%	3,224 $223,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $5,204 - $6,762	-96 Reduced 2.37%	3,952 $267,000
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $2,173 - $5,565	-41 Reduced 1.0%	4,048 $222,000
Q2 2022 Aug 05, 2022	BUY	$59.26 - $71.14 $2,548 - $3,059	43 Added 1.06%	4,089 $270,000
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $27,247 - $32,821	489 Added 13.75%	4,046 $268,000
Q4 2021 Feb 04, 2022	BUY	$54.02 - $63.83 $10,912 - $12,893	202 Added 6.02%	3,557 $207,000
Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $186,403 - $203,950	3,355 New	3,355 $201,000

Others Institutions Holding AZN

# of Institutions

1,334

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.

Account

Souders Financial Advisors Astrazeneca PLC Transaction History